An overview of ASTM D4169 transit testing for pharma and medical devices

Your industry, our focus

First published: June 2026

In pharmaceutical and medical device distribution, packaging does far more than contain a product. It protects efficacy, sterility, usability, and compliance from the moment goods leave production until they reach the end user. When products move through complex distribution networks, every handover, vibration event, compression load and impact introduces risk. This is why effective pharma transportation planning and medical device transit testing are so important to reducing supply chain risk.

This article delves into ASTM D4169 testing, which provides a structured framework for evaluating shipping units using established test methods, helping organisations assess how packaging systems perform under real-world distribution hazards.

Need testing services? Our laboratory in Noida, India, has expanded its testing capabilities to support pharma and medical device transit testing in accordance with ASTM D4169.

As an ASTM D4169 testing lab, we support manufacturers looking to validate packaging performance for regulated supply chains. This, paired with the robust transit testing services in our global laboratory network, ensures we have the capacity and capabilities to support you the best. Contact us here if you require ASTM D4169 testing or testing to other standards, such as ISTA.

The risks hiding in your supply chain

Transit risk is often cumulative rather than dramatic. A single drop may not cause visible damage, but repeated vibration, compression and impacts over time can weaken a packaging system, compromise product presentation or affect a sterile barrier.

In pharma and medical devices, the consequences of failure are particularly serious. Damaged packaging can lead to product wastage, stock write-offs, delayed supply, exposure to temperature excursions, sterility concerns, relabelling, rework, and regulatory scrutiny. Even where the product itself remains functional, poor packaging performance can reduce customer confidence and create avoidable friction across the supply chain.

ASTM D4169 helps reduce that risk by turning packaging validation into a measurable, evidence-based process. It allows you to understand not only whether a pack survives distribution, but where its margins are thin and where targeted improvements could strengthen performance. This makes ASTM D4169 testing a valuable part of packaging validation for both pharmaceutical products and medical devices.

Understanding ASTM D4169 for safer transit packaging

ASTM D4169 is a recognised distribution simulation standard used to assess how shipping units perform under the hazards of transport, handling, and storage. It is also widely recognised as a key route for transit simulation of sterile barrier systems and is referenced as an FDA-recognised consensus standard in that context.

In simple terms, it is designed to help manufacturers understand whether a packaged product can withstand the conditions it is likely to face across the supply chain, before those risks appear in live distribution. For companies involved in pharma transportation or medical device transit, ASTM D4169 testing helps validate whether packaging can perform under real distribution conditions.

The standard uses a structured approach based on selected distribution cycles, test schedules and assurance levels, so the test programme can be aligned to the expected shipping environment.

The exact test sequence depends on the chosen distribution cycle, but ASTM D4169 typically includes tests that simulate the most common hazards seen during transit. These can include manual handling and drop events, vehicle vibration, compression or stacking loads, and impact or horizontal shock events. Some programmes may also include additional conditions relevant to the expected distribution route, depending on how the shipping unit is handled and transported.

ASTM D4169 includes 18 distribution cycles, 10 test schedules and 3 assurance levels, with the assurance level determining how severe the testing conditions will be.

The 18 distribution cycles of ASTM D4169

DC 1 – General cycle, undefined distribution system
Used when the distribution environment is broad or not clearly defined.
DC 2 – Specially defined distribution system, user specified
Used when the customer or manufacturer defines a specific custom distribution profile.
DC 3 – Single package without pallet or skid, LTL motor freight
For individual packs shipped by less-than-truckload road freight without palletisation.
DC 4 – Single package with pallet or skid, LTL motor freight
Similar to DC 3, but for loads supported on a pallet or skid.
DC 5 – Motor freight, TL, not unitised
For truckload road freight where the load is not unitised into one stable pallet load.
DC 6 – Motor freight, TL or LTL, unitised
For palletised or otherwise unitised freight travelling by truckload or less-than-truckload.
DC 7 – Rail only, bulk loaded
For shipments moving only by rail in bulk-loaded format.
DC 8 – Rail only, unitised
For rail shipments where the load is unitised, such as palletised freight.
DC 9 – Rail and motor freight, not unitised
For mixed rail and road distribution where the shipment is not unitised.
DC 10 – Rail and motor freight, unitised
For combined rail and road transport with palletised or unitised loads.
DC 11 – Rail, trailer on flatcar or container on flatcar
For intermodal rail transport involving trailers or containers carried on flatcars.
DC 12 – Air (intercity) and motor freight (local), over 150 lb, or unitised
For heavier or unitised shipments moving through air freight plus local road transport.
DC 13 – Air (intercity) and motor freight (local), single package up to 150 lb
For smaller individual shipments moving by air and local road distribution.
DC 14 – Warehousing
For risks primarily associated with storage and warehouse handling.
DC 15 – Export/import shipment for intermodal container or roll-on/roll-off trailer
For international movements using containers or RoRo trailer systems.
DC 16 – Export/import shipment for palletised cargo ship
For international sea freight where goods are palletised.
DC 17 – Export/import shipment for break-bulk cargo ship
For overseas shipping where cargo is loaded individually rather than in standard containers.
DC 18 – Non-commercial government shipments per MIL-STD-2073
For certain government or military-style shipment profiles.

The 10 test schedules of ASTM D4169

Schedule A – Handling, manual and mechanical
Simulates handling events such as drops, impacts and stability-related challenges during movement.
Schedule B – Warehouse stacking
Simulates compressive loads caused by stacking during storage in a warehouse.
Schedule C – Vehicle stacking
Simulates compression loads created when packages are stacked during transport.
Schedule D – Stacked vibration
Simulates vibration while the load is stacked, reflecting dynamic transport conditions.
Schedule E – Vehicle vibration
Simulates vibration experienced during vehicle transport.
Schedule F – Loose load vibration
Simulates repetitive shock and vibration when a package moves as part of a loose load.
Schedule G – Rail switching
Simulates longitudinal shock, such as the jolts seen in rail yard switching operations.
Schedule H – Environmental hazard
Simulates temperature and humidity exposure that may affect packaging performance.
Schedule I – Low pressure hazard
Simulates vacuum or reduced-pressure conditions, relevant especially for air transport.
Schedule J – Concentrated impact
Simulates a localised impact force on a specific area of the pack.

The 3 assurance levels of ASTM D4169

Assurance Level I – Highest severity
The most severe and conservative level, used where the distribution environment is harsh or the risk tolerance is very low.
Assurance Level II – Medium severity
The intermediate level and often the most commonly selected option for general distribution testing.
Assurance Level III – Lowest severity
A less severe challenge level, used where the expected distribution hazards are lower or a lighter test profile is justified.

How can Eurofins Softlines & Hardlines support pharma and medical devices transit testing?

Our laboratory in Noida, India, has recently expanded its testing capabilities to support pharmaceutical and medical device transit testing in accordance with ASTM D4169. As an ASTM D4169 testing laboratory, we help manufacturers assess packaging performance for regulated healthcare products.

The laboratory is equipped with state-of-the-art testing equipment to simulate a wide range of distribution and environmental conditions, including high altitude testing, air cargo simulation, transportation testing, packaging validation, and environmental testing. This allows us to help manufacturers assess whether their packaging systems can withstand the real-world hazards encountered throughout the supply chain. Our capabilities are designed to support both medical device transit testing and the demands of modern pharma transportation.

Because ASTM D4169 includes 18 distribution cycles, 10 test schedules and 3 assurance levels, it is important to define the most appropriate testing programme for each product, packaging format and distribution route. In simple terms, our experts recommend thinking about ASTM D4169 in the following way:

Distribution cycle = Where and how the shipment travels
Test schedule = What hazards are simulated
Assurance level = How tough the test is

Our team can help you identify the most suitable approach for your pharmaceutical or medical device packaging, based on your product type, supply chain profile and validation objectives. If you would like expert guidance on developing an ASTM D4169 testing programme, we encourage you to contact us directly.

In addition to ASTM D4169, we also support testing against a wide range of other recognised standards, including:

ISTA: 1-series, 2-series, 3-series, 6-Amazon.com-SIOC Project, 6-Amazon.com-Over boxing Project
ASTM: D642, D880, D996, D999, and more
ISO: 2759:2014
TAPPI: T810, T811, T839, T410

Contact us today for safer transit packaging, medical device transit testing, pharma transportation support, and to reduce supply chain risk.